Average Co-Inventor Count = 9.30
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Schering Corporation (27 from 1,829 patents)
2. Merck Sharp + Dohme Corp. (12 from 2,405 patents)
3. Dendreon Corporation (4 from 53 patents)
4. Southern Research Institute (2 from 203 patents)
5. Merck Canada Inc. (1 from 40 patents)
6. Msd Italia S.r.l. (1 from 7 patents)
7. Disc Medicine, Inc. (1 from 3 patents)
40 patents:
1. 12428415 - Matriptase 2 inhibitors and uses thereof
2. 11161819 - Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists
3. 9708270 - Substituted spiropiperidinyl compounds useful as GPR120 agonists
4. 9433621 - Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
5. 9328138 - HCV NS3 protease inhibitors
6. 8987195 - HCV NS3 protease inhibitors
7. 8901139 - Tricyclic indole derivatives and methods of use thereof
8. 8697694 - Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
9. 8614229 - Substituted indole derivatives and methods of use thereof
10. 8557848 - 4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
11. 8546420 - 4, 5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
12. 8404845 - 2,3-substituted azaindole derivatives for treating viral infections
13. 8268803 - 5, 6-ring annulated indole derivatives and use thereof
14. RE43298 - Peptides as NS3-serine protease inhibitors of hepatitis C virus
15. 8143305 - 2,3-substituted indole derivatives for treating viral infections